|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/496 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/5375 | (2013.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/5375 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/4412 | (2013.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 31/517 | (2013.01) | ||
| A61K 31/5377 | (2013.01) | ||
| A61K 31/635 | (2013.01) |
| (11) | Number of the document | 3340989 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16760803.3 |
| Date of filing the European patent application | 2016-08-24 | |
| (97) | Date of publication of the European application | 2018-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/055050 |
| Date | 2016-08-24 |
| (87) | Number | WO 2017/037579 |
| Date | 2017-03-09 |
| (30) | Number | Date | Country code |
| 201562211080 P | 2015-08-28 | US | |
| 201562243337 P | 2015-10-19 | US | |
| 201562250574 P | 2015-11-04 | US |
| (72) |
HALILOVIC, Ensar , US
CAPONIGRO, Giordano , US
HORN-SPIROHN, Thomas , US
LEHAR, Joseph , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | MDM2 INHIBITORS AND COMBINATIONS THEREOF |
| MDM2 INHIBITORS AND COMBINATIONS THEREOF |